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ABSTRACT The plasma membrane W -ATPase of the yeast Saccharomyces cerevisiae is a prototype for the mutagenic analysis of
structure-function relationships in P-type cation pumps. Because a functional W pump is required for viability, wild-type ATPase
must be maintained in the plasma membrane for normal cell growth. Our expression strategy involves a rapid switch in expression
from the wild-type ATPase gene to a mutant allele followed by entrapment of the newly synthesized mutant enzyme in an internal,
secretory vesicle pool. The isolated vesicles prove to be ideally suited for the study of the catalytic and transport properties of the
ATPase. Work to date has focused on conserved residues in the vicinity of the aspartyl-phosphate reaction intermediate.
Substitution of Asp378 with Glu, Ser, or Asn and of Lys379 with Gin prevents normal biogenesis of the mutant ATPase. The more
conservative Lys379 -+ Arg mutation was tolerated, but with a sixfold loss of activity and substantial alterations in Km for ATP and Ki
for vanadate. Nonconservative replacement of Thr380, Thr382, or Thr384 with Ala led to inactive enzyme, whereas the conservative
change to Ser caused a two to threefold reduction in ATP hydrolysis and W -pumping. Taken together, the results are consistent
with an essential role for these invariant residues in phosphate-binding and ATP hydrolysis.
INTRODUCTION
A family of cation pumps known as the P-type ATPases
occur ubiquitously in the plasma membranes and intra-
cellular membranes of all cells (reviewed by Pedersen
and Carafoli, 1987; Serrano, 1988). These ATP-depen-
dent transporters generate ion gradients across the
membrane, which play an important role in the mainte-
nance of cellular milieu, uptake of nutrients, regulation
of pH, and signal transduction. Examples include the
K+-ATPase of bacteria, H+-ATPase of fungi and plants,
and the Caz+-ATPase, H+ /K+-ATPase, and Na+ /K+-
ATPase of animal cells. Although the specificity and
stoichiometry for the transported ion varies, the cation-
transporting ATPases exhibit familial similarities in
sequence, structure, and catalytic mechanism. Common
features include (a) the presence of a 100 kDa catalytic
subunit which is embedded in the lipid bilayer by 8-10
transmembrane helices, (b) transient phosphorylation
by ATP at a conserved aspartate residue, (c) passage
through at least two distinct conformations, known as E 1
and Ez, during the course of catalysis, and (d) inhibition
by micromolar concentrations of the phosphate ana-
logue orthovanadate.
Data obtained from chemical modification, limited
proteolysis, and studies with antibodies have been com-
bined with sequence alignments, hydropathy analyses,
and secondary structure predictions to derive working
models of several of the P-type ATPases (e.g., Serrano,
1988; Nakamoto et aI., 1989). Fig. 1 illustrates a topolog-
ical model of the plasma membrane H+-ATPase from
the yeast Saccharomyces cerevisiae, which serves as a
prototype of a eukaryotic cation pump; the model
relates closely to those proposed for the sarcoplasmic
reticulum and plasma membrane Caz+-ATPases of mam-
malian cells (MacLennan and Reithmeier, 1985; Ca-
rafoli, 1991). The polypeptide chain is organized into
alternating hydrophobic and hydrophilic stretches with
four clearly defined transmembrane segments in the
NHz-terminal half, a central hydrophilic domain, and
four to six COOH-terminal transmembrane segments.
The hydrophobic stretches anchor the protein in the
membrane and are believed to be assembled into a
channel-like structure through which cations must pass.
Segment 4 is the best conserved of the transmembrane
helices and has been proposed to form part of the energy
transduction pathway (Shull et aI., 1985). Closely follow-
ing this segment is the phosphorylation domain which is
the site of the aspartylphosphate reaction intermediate.
The remainder of the large hydrophilic domain is
organized into a nucleotide-binding ("Rossman") fold
which is involved in ATP-binding and hydrolysis (Ser-
rano, 1988; Taylor and Green, 1989; Rao et aI., 1989). A
smaller hydrophilic domain occurs between membrane
segments 2 and 3 and may have a phosphatase-like
function (Serrano and Portillo, 1990). Both NHz and
COOH termini have been shown to be cytoplasmically
located in the closely related enzyme from Neurospora
crassa (Mandala and Slayman, 1989). At the NHz-
terminus is a highly acidic stretch of amino acids of
unknown function, whereas the COOH-terminus ap-
pears to have a regulatory role (Portillo et aI., 1989). A
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FIGURE 1 Structural model of the plasma membrane H+-ATPase.
The polypeptide chain is predicted to loop through the lipid bilayer,
forming eight membrane-spanning helices (MI-M8). Less than five
percent of the protein occurs on the extracellular surface; both NH,
and COOH termini and the bulk of the hydrophilic section are located
in the cytoplasm and organized into discrete domains, as described in
the text.
detailed model of ATP-driven proton transport awaits
direct structural information from x-ray crystallography.
Meanwhile, the model provides the basis for the analysis
of structure-activity relationships using the powerful
tool of mutagenesis.
Mutational analyses of several cation pumps are
already underway and have begun to yield useful infor-
mation on the role of specific residues in catalysis
(McCusker et aI., 1987; Maruyama et aI., 1989; Serrano
and Portillo, 1990; Ohtsubo et aI., 1990). A prerequisite
for such studies is the availability of a suitable expression
system in which the functional consequences of altering
enzyme structure can be readily analysed. The yeast
Saccharomyces cerevisiae offers an ease of biochemical
and genetic manipulation unequalled by other eukary-
otes. We describe here the development of a novel
system for the expression and mutagenesis of the plasma
membrane H+-ATPase from yeast. The method should
be of general utility for the systematic dissection of
structure-function relationships in other yeast transport-
ers, and may also be suitable for the heterologous
expression of mammalian ATPases in yeast.
Strategy for the expression of mutant
ATPases in yeast
A suitable expression system for the H+-ATPase should
have the following properties: (a) during growth, the
wild-type copy of the ATPase gene should be expressed
to support normal cell physiology, whereas the mutant
copy should remain off to preclude toxic effects of the
abnormal protein, (b) at the desired time, one should be
able to switch rapidly from the wild-type to the mutant
allele, and (c) after the switch, background activity from
the wild-type enzyme should be minimal, whereas the
mutant protein should be abundantly produced to pro-
vide sufficient material for analysis.
These requirements have been met by placing wild-
type and mutant copies of the ATPase gene behind
different inducible promoters and by targeting the mu-
tant protein to a separate, internal membrane pool. In
yeast, it is known that plasma membrane proteins
synthesized in the rough endoplasmic reticulum are
sorted in the Golgi apparatus and conveyed to the cell
surface by transiently existing secretory vesicles. Temper-
ature-sensitive mutations in a series of sec genes cause
specific blocks in the transport machinery, resulting in
the accumulation of intermediary compartments at the
restrictive temperature (Schekman and Novick, 1982);
in this way, de novo synthesized proteins may be en-
trapped in specific membrane compartments.
Our strategy is to isolate mutant H+-ATPase in
secretory vesicles en route to the plasma membrane. The
temperature-sensitive sec6-4 mutation blocks fusion of
the secretory vesicles with the plasma membrane; after a
shift in temperature from 23 to 37°C, cells cease to
divide and rapidly become filled with vesicles. We have
constructed the yeast strain SY4 (Nakamoto et aI., 1991)
carrying the sec6-4 mutation along with a chromosomal
copy of the wild-type PMA1 gene encoding the H+-
ATPase under control of the GALl promoter. For
expression studies, SY4 is transformed with a plasmid
carrying a mutant ATPase allele controlled by the
inducible heat shock promoter. As depicted in Fig. 2,
wild-type ATPase (represented by the solid circles) is
correctly routed to the plasma membrane when the cells
are grown in galactose at 23°C; under these conditions,
the mutant allele is not expressed. When the cells are
shifted to glucose medium at 37°C, however, there is a
rapid and complete switch in expression from the
wild-type to mutant gene. Simultaneously, a secretory
block is imposed, leading to the accumulation of secre-
tory vesicles containing only mutant enzyme (repre-
sented by the stippled diamonds).
METHODS
Isolation of secretory vesicles
Fig. 3 depicts a flowchart for the purification of secretory vesicles from
strain SY4. Cells are grown in galactose medium at 23°C to mid-
exponential phase and then transferred to two percent glucose
medium to allow the decay of chromosomally encoded PMAI tran-
script. Next, the temperature is shifted to 37°C, simultaneously
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Galactose, 23°C Glucose, 370C
FIGURE 2 Strategy for the expression of mutant ATPases in yeast. In galactose medium at 23°C, the chromosomal gene PGAL-PMAI is on and the
plasmid-borne mutant allele PHsE-pmal is off, so that wild-type H+-ATPase (e) is expressed and conveyed to the plasma membrane along the
secretory pathway. At the desired time, cells are shifted to glucose medium at 37°C. The wild-type ATPase gene is turned off, the mutant allele is
turned on and a secretory block (caused by the sec6-4 mutation, see text) is imposed. As a result, secretory vesicles carrying only mutant H+ATPase
(0) rapidly accumulate and fill the cell. The vesicles are isolated and analysed for H+-pump activity as described under Methods.
FIGURE 3 Flowchart for the isolation of secretory vesicles. The
purification protocol is described in further detail under Methods.
imposing the secretory block and turning on expression of the
plasmid-borne ATPase gene. After accumulation of vesicles, the cells
are converted to spheroplasts in an isoosmotic medium (1.4 M sorbitol,
50 mM K2HPO., pH 7.5, 10 mM NaN" 40 mM ~-mercaptoethanol
containing 0.2 mg/ml zymolyase) and coated with concanavalin A (25
mg/l,600 OD600 units of cells in spheroplasting medium containing 10
mM MgCI2 ). The lectin binds to glycoproteins on the cell surface and,
upon subsequent lysis of the spheroplasts, produces large sheets of
plasma membranes that sediment at low centrifugal forces (Smith and
Grow sec6-4 cens in galactose, 23°C
+overniQht
Shift to glucose, 23°C
i3 h
Shift to 37°C
i2 h
Convert to spheroplasts in 1.4 M sorbitol, 37°C
~ 45 min.
Coat spheroplasts with concanavalin A, ooei 15 min.
Lyse in 0.8 M sorbitol
i
Switching expression from the
chromosomal to the plasmid-borne
PMA1 gene
To place the chromosomal, wild-type copy of the ATPase
gene behind the inducible GALl promoter, an integrat-
ing plasmid was used in conjunction with a standard
gene disruption strategy (Nakamoto et aI., 1991). The
resulting strain SY4 (MATa, ura3-52, leu2-3,112, his4-
619,sec6-4, GAL,pma1::YIpGAL-PMA1) is maintained
at 23°C on supplemented minimal medium containing
two percent galactose. For control experiments, a sec-
ond copy of the wild-type PMA1 gene was cloned into a
yeast centromeric plasmid behind two tandemly ar-
ranged copies of the yeast heat-shock promoter (Slater
and Craig, 1987; Nakamoto et aI., 1991) to give the
plasmid, YCp2HSE-PMAl.
In the experiment of Fig. 4, secretory vesicles were
isolated from SY4 cells that were (a) maintained in
galactose at 37°C during accumulation of vesicles (chro-
mosomal gene on), (b) shifted to glucose as depicted in
Scarborough, 1984). In practice, the inclusion of this step in the
purification protocol reduces plasma membrane contamination approx-
imately fivefold (data not shown) so that the background level of
wild-type H+-ATPase in purified secretory vesicles is extremely low
(see below). Next, spheroplasts are disrupted with 20 strokes of a
Dounce homogenizer in a mildly hypoosmotic medium (0.8 M sorbitol,
10 mM triethanolamine, pH 7.2, 1 mM EDTA). The lysate is subjected
to low speed centrifugation to remove cell debris, plasma membranes,
and other organelles; the vesicles remain in the supernatant and are
collected by high speed centrifugation (Fig. 3). At this stage, the
membrane pellet is either washed in 1 mM EGTA/Tris, pH 7.5, to give
a crude preparation of vesicles suitable for initial characterization of
H+-ATPase activity, or purified further by gel filtration (Nakamoto et
aI., 1991). The latter step has routinely been employed for the analysis
of mutant enzymes (see below).
I
Supernatant (52)
soluble proteins
I
Supernatant (51)
i
Centrifuge 100 k g, 1 h
I
I
Sephacryl S-1 000 chromatography
i
pool turbid fractions, wash in EGTAITris
purified secretory vesicles
J
Penet (P2)
I
Centrifuge 10k g, 10 min.
I
I
Wash in EGTAfTris (P3)
crude secretory vesicles
I
Penet (P1)
cell debris, nuclei, mitochondria,
pltlsma membranes
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orange fluorescence was observed only under conditions
of PMA1 gene expression (Fig. 5 B; [i] and [ii]).
Oligonucleotide-directed mutagenesis using the Amer-
sham in vitro mutagenesis kit (Amersham Corp., IL) was
employed to generate site-specific changes in a 496 base
pair Styl to BamHl fragment of the PMA1 gene (Ser-
rano et aI., 1986) which had been cloned into Bluescript
(Stratagene, LaJolla, CA). The entire fragment was
sequenced to verify the presence of the mutation and the
absence of other unwanted changes. The mutagenized
fragment was then subcloned into the remainder of the
PMA1 gene on the yeast expression vector YCp2HSE-
PMA1, which was subsequently transformed into strain
SY4 by the method of Ito et aI. (1983).
Construction of mutants
FIGURE 5 Transport properties of secretory vesicles. (A) Assay of
~pH. In the standard assay, a suspension of vesicles (0.2 mg/ml) is
incubated in 10 mM Hepes/KOH, pH 6.7,100 mM KCl, 2 110M acridine
orange (A.O.) and 5 mM ATP. Proton pumping is initiated by the
addition of 5 mM MgClz. ATP is hydrolysed on the outer surface of the
membranes and protons are translocated inward, leading to the
development of ~pH which is monitored by quenching of acridine
orange fluorescence. (B) H+-pump activity in isolated secretory
vesicles. Preparations of vesicles from SY4 grown in galactose (a), or
shifted to glucose in the presence (b), or absence (c) of a plasmid
carrying a second copy of the PMAI gene were made as in the
experiment of Fig. 4. Fluorescence of acridine orange was monitored
as described above. Arrows indicate the addition of MgClz (Mg),
vanadate (VO.), and NH.CI.
1 min
A. ATPPGAl- PMAl ON OFF OFF
F\iSE- PMAl OFF OFF ON
AD? + Pi
100kDII~
A.a.
SA. 1.33 0.09 3.21 Mg
I'moles/mln,lmg I NH.CIB. (I) IH+-pumplng 11.8 0 23.6
" Quench/min (ii)
Characterization of secretory vesicle
ATPase
Before utilizing the new expression system for the
analysis of mutant ATPases it was necessary to show that
the catalytic properties of wild-type H+-ATPase from
secretory vesicles are identical to those of ATPase
derived from the plasma membrane. Secretory vesicles
and plasma membranes were purified from a sec6-4
strain (NY1?) and characterized in detail (Nakamoto et
aI., 1991). Table 1 summarizes the results of this study
and demonstrates that the secretory vesicle ATPase is a
mature, catalytically active form of the plasma mem-
brane enzyme.
An additional, attractive feature of the expression
system is the orientation of the ATPase in the lipid
bilayer. ATP is split at the outer surface of the vesicles
and protons are pumped inward, producing an acid-
interior pH gradient that can be followed using a
pH-sensitive fluorescent probe. Fig. 5 shows the assay of
H+-pumping for the three preparations of secretory
vesicles described in Fig. 4. Strong quenching of acridine
Fig. 3 (chromosomal gene oft), and (c) transformed with
plasmid YCp2HSE-PMAl and shifted to glucose as in
the previous case (plasmid gene on). As expected, an
immunologically-reactive band of 100 kDa was seen in
the first sample, disappeared in the second, and reap-
peared in the third (Fig. 4). Vanadate-sensitive ATPase
activity and the relative rate of H+-pumping in these
preparations (Fig. 5) also reflected a rapid and complete
switch in expression from the chromosomal to the
plasmid-encoded PMA1 gene.
FIGURE 4 Control of ATPase expression from GALl and HSE
promoters. Differential induction of promoters was achieved by
switching carbon source and temperature as described in the text.
Secretory vesicles were purified from strain SY4 under the three
conditions shown and analysed for the presence of a 100 kDa band by
Western blotting, specific activity of ATP hydrolysis and relative rate
of H+-pumping as described in the text.
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Biochemical methods
Isolation of plasma membranes, assays of ATP hydroly-
sis and H+-pumping, protein determinations, electro-
phoretic and Western Blot methods, and reagents used
in this study have been described previously (Nakamoto
et aI., 1991).
'Plasma membranes (PM) and secretory vesicles (SV) were isolated as
described under Methods from strain NY17 (AMTa, ura3-52, sec6-4)
grown on YP medium containing 2% glucose (Nakamoto et al., 1991);
IATPase activities were measured at 30°C in 50 mM MES/Tris, pH 6.5,
5 mM MgCl" 5 mM ATP, 5 mM phosphoenolpyruvate, 11 mM
(NH,),SO" and 0.05 mg/ml pyruvate kinase; IKN" bafilomycin, and
(NH,),MoO, are diagnostic inhibitors of mitochondrial FIFo-type
H+-ATPase, vacuolar H+-ATPase, and acid, and alkaline phos-
phatases, respectively.
TABLE 1 Comparison of W -ATPase activity in plasma
membranes and secretory vesicles RESULTS AND DISCUSSION
Structure of the phosphorylation
domain
A hallmark of all P-type ATPases is the formation of a
13-aspartyl phosphate reaction intermediate. When amino
acid sequences in the vicinity of this residue are com-
pared, a high degree of conservation is seen through the
evolutionary ladder (Fig. 6). Not surprisingly, secondary
structures predicted by the algorithms of Chou and
Fasman (1974) and Gamier et al. (1978) also show
strong similarities, allowing a consensus structure to be
derived. The phosphorylated aspartate residue occurs in
a beta-tum, as part of a helix-turn-strand motif, and is
closely preceded by the well-conserved membrane seg-
ment 4. After the phosphorylation domain, the sequence
diverges in the different enzymes before reaching the
nucleotide-binding domain that is once again strongly
conserved. In the course of catalysis, the phosphoryla-
tion domain must interact closely with the nucleotide-
binding site to allow for the transfer of the -y-phosphate
ofATP.
Fig. 6 depicts the residues that were targets for
mutagenesis in this study; also shown is the Ser ~ Phe
change at position 368 that has been previously de-
scribed (McCusker et aI., 1987; Nakamoto et aI., 1991).
In each case, conservative replacements (Asp ~ Glu,
Lys ~ Arg, and Thr ~ Ser) were made; additional
SV
1.72
1.5
1.6
1.8
6.2
none
none
1.3
6.2
1.2
1.74
1.9
PM'
none
none
Specific Activity' (~mol/min/mg)
pH optimum
Nucleotide specificity and affinity
ATPase Km (in millimolar)
Hill coefficient
GTPase
Sensitivity to inhibitors
Vanadate Ki (in micromolar)
5 mM KN" 100 nM bafilomycin,
200 ~M (NH,),MoO,1
F
S
N Q A A A
E R S S S
C SDK T G T L T Q N R M T V
C SDK T G T L T T NI§]M S V
C SDK T G T L T M N R M T V
K T G T L T Q N R M T V
K T G T L T L N K MEl
K T G T L T L N K L S V
K T G T L T K N K L S L
L 0 K T G TIT L G N R Q A
KTGTLTQG~F~
K T G T L T I G~P R~
A VET L G
A M E Q AND
AM E RBE
A I E S LAG V ElL C S 0
A I E filM A G M 0 V L C S 0
A I E~M S G V N M L C S 0
A VET L G S T S V I C S 0
s. cerevisiae (H) (365-390)
Arabidopsis (H) (316-341 )
Leishmania (H) (378-403)
Gastric (H/K) (372-397 )
PM (Na/K) (361-386 )
SR (Ca) (338-363)
PM (Ca) (462-487)
E. coli (K) (294-319)
s. faecalis (K) (265-290)
Rhizobium (7) (441-466)
Cho,,-Fasman
Garnier-Osguthorpe-Robson
FIGURE 6 Conservation of structure in the phosporylation domain. Alignment of ATPase sequences and predictions of secondary structure using
the algorithms of Chou and Fasman (1974) and Gamier et al. (1978) were performed as described in Rao et al. (1989). Conserved amino acids are
enclosed in boxes. Amino acid substitutions of the yeast sequence made in this work are indicated by arrows. The S368F mutation described earlier
(McCusker et aI., 1987; Nakamoto et aI., 1991) is also shown for reference. The bars, zigzag lines, and diamonds represent a-helices, l3-strands, and
turns.
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TABLE 2 Effect of amino acid substitutions in the
phosphorylation domain
changes were designed to cause minimum perturbation
of protein structure (Asp ~ Asn, Ser; Lys ~ GIn,
Thr ~Ala). Expres-
ATPase sion*
ATP
hydrolysisl
KIn Ki
(ATP) (vanadate) H+-pumping!
*The amount of mutant ATPase protein in each preparation of
secretory vesicles was determined by an immunodot blot procedure
using a specific anti-ATPase antibody and t25I-protein A. The relative
expression level of the mutant ATPase was calculated from a standard
curve constructed with known amounts of wild-type secretory vesicles;
lrates of ATP hydrolysis represent the component sensitive to inhibi-
tion by vanadate (500 J.l.M) with the exception of the vanadate-
insensitive K379R enzyme for which total ATPase activity is pre-
sented. Activities are not corrected for the relative levels of ATPase
protein; !rates are not corrected for the relative levels of ATPase
protein; llJackground activities are derived from strain SY4, in the
absence of plasmid containing PMA1 gene.
the polypeptide chain. Nonconservative replacements of
each threonine with alanine led to inactive enzyme.
Individual conservative substitutions to serine reduced
enzyme activity by 55-70% (after correction for the
reduced amount of ATPase protein), with the central
threonine replacement being somewhat more deleteri-
ous (Table 2). H+-pumping activities were commensu-
rate with rates of ATP hydrolysis. Changes in Km for
ATP were not significant (with the exception of the
T380S enzyme), but the Ki for vanadate was increased 7,
23, and 3-fold, respectively, for the T380S, T382S, and
T384S replacements. A triple mutation of all three
threonines to serines resulted in loss of ATPase activity
and a more severe reduction in level of expression
(Table 2). All three threonines, therefore, appear to be
essential for activity. A subtle shift in the placement of
the hydroxyl group of anyone allows for the retention of
partial activity, but a concerted change in the position of
all three hydroxyls is poorly tolerated. Based on these
data, the conserved threonines may be hypothesized to
interact with one or more of the phosphate groups of
bound ATP. Alternatively, the hydroxyl groups may play
0.31 0.35 >500 -0
1.0 0.48 7.0 11.7
0.11
0.58 1.44 23 9.2
0.09
0.98 2.12 3.0 14.2
0.10
0.06
percent JU1lol/min /mg mM Quench
(percent) Imin
29.21.03.1 1.39
0.09
Wild-type 100
Nonel
D378E 0
D378N 0
D378S 0
K379R 65
K379Q 0
T380S 72
T380A 34
T382S 58
T382A 29
T384S 75
T384A 14
T380,382,
384S 29
Effects of mutations in the
phosphorylation domain
(a) Asp378: Mutations at this site prevented delivery of
the ATPase to the secretory vesicles, although full-
length protein was detected by metabolic labelling (not
shown). The mutant enzymes appeared to be retained in
the Golgi compartment and to have no detectable
activity (Nakamoto, R. K., and S. Verjovski-Almeida,
manuscript in preparation). This result is in accordance
with the critical role of Asp378 in catalysis; it is remark-
able that even a conservative replacement with gluta-
mate was not tolerated. Similar observations have been
made on mammalian Caz+- and Na+/K+-ATPases
(Maruyama and MacLennan, 1988; Ohtsubo et aI.,
1990). An earlier, surprising report by Portillo and
Serrano (1988) that substitutions of Asp378 on the yeast
H+-ATPase with glutamate, asparagine and threonine
resulted in a functional enzyme, now appears to be
incorrect (Serrano, R., personal communication).
(b) Lys379: A nonconservative mutation of this invari-
ant residue to glutamine led to a failure in targeting of
the altered protein to secretory vesicles, as observed for
the Asp378 replacements. However, a more conserva-
tive replacement with arginine was tolerated with a large
loss of catalytic activity and some impairment in the level
of expression (Table 2). The rate of ATP hydrolysis was
reduced by more than sixfold (after compensation for
the lower levels of protein), whereas there was no
detectable H+-pumping activity as determined by the
acridine orange assay (Fig. 5). The apparent Km for
ATP was lowered; however, the most significant alter-
ation in activity was the relative insensitivity to inhibition
by vanadate. The shift in Ki for vanadate reflects either a
decrease in the affinity for the inhibitor or a displace-
ment in equilibrium away from the Ez conformation
believed to bind vanadate. In view of the immediate
proximity of Lys379 to the site of phosphorylation, a
large change in affinity of the mutant for the phosphate
analogue vanadate is not surprising. In addition, struc-
tural aberrations in this critical region might be expected
to lead to a displacement in the equilibrium between
conformational states of the enzyme. The phosphoryla-
tion domain, along with the adjacent, highly conserved
membrane segment 4, may be a focal point for conforma-
tional coupling of ATP hydrolysis to H+-pumping.
(c) Thr380, Thr382, Thr384: There are three con-
served threonines in the phosphorylation domain which,
interestingly, are located in an alternating pattern along
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a structural role in stabilizing the l3-strand that is
predicted to follow the tight turn (Fig. 6) by hydrogen
bonding with an adjacent strand of the polypeptide
chain.
CONCLUSION
In summary, we have demonstrated the use of a new
strategy for the expression of the plasma membrane
H+-ATPase in yeast. The method allows for mutagenic
analysis of a gene essential for cell viability by sequester-
ing the mutant protein in an internal, secretory vesicle
pool. The vesicles may be conveniently isolated in
sufficient amount and purity for characterization of
ATPase activity. Furthermore, the vesicles are tightly
sealed and of homogeneous orientation, suitable for
assays of proton transport. We have analyzed the role of
conserved residues in the phosphorylation domain as a
first step in the dissection of structure-activity relation-
ships of the plasma membrane H+ pump by mutagenen-
sis.
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DISCUSSION
Session Chairman: Ira Levin Scribes: Marc Glucksman and Claire L.
Careaga
JOHN DURKIN: I'm most interested in the knockout mutation of
aspartate 378. The residue plays a critical role in catalysis. What you
describe in the paper indicates that these mutations are deficient in
targeting and processing. Let me ask some open ended questions: (a)
The ATPase doesn't make it into the secretory vesicles, but are the
mutants active? Can you extract them from the cells with detergent
and reconstitute them to unmask activity? (b) How quickly are they
degraded? Are they "hanging around" or rapidly shunted into some
degradative compartment? (c) How does a mutation so far from the
signal sequence lead to a deficiency in targeting and processing?
RAJINI RAO: We know from metabolic labeling studies that these
particular mutant proteins are synthesized near wild-type levels and
are not rapidly degraded. We also know that the proteins are retained
in the Golgi and not processed further.
DURKIN: What is the evidence for that?
RAO: Subcellular fractionation and specific Golgi markers. In a yeast
strain carrying the Golgi-accumulating mutationsec7, both mutant and
wild-type proteins are retained in the Golgi and migrate identically.
We are attempting to assess the activity of these mutants. However, it
is difficult to isolate a pure Golgi fraction. One approach to examining
folding is limited trypsinolysis of metabolically-labeled mutant protein
in the presence of ligands (ATP, vanadate) to yield specific protein
fragments. There may be a correlation between reduction in ATPase
activity and in the level of ATPase protein found in secretory vesicles.
One intriguing possibility is that the ATPase may need to pump
protons into the Golgi or it may assume a distinct conformation that is
dependent on activity in order to be correctly processed. There is no
known signal sequence for this protein.
DURKIN: It is a fascinating idea that the proton pumping activity may
be necessary for the enzyme to leave the Golgi to the secretory vesicles.
But many proteins are secreted that are not proton pumps. Do you
think this requirement is common in secretion or something peculiar
to this enzyme?
RAO: If I understand you, we don't see an effect on the processing of
other proteins. There are no differences from protein gels stained with
Coomassie or silver.
DURKIN: That is a very good observation.
JOE FALKE: Another possible explanation for the high conservation
of aspartate 378 is that it is an essential residue for folding, rather than
active site chemistry. Has the site of phosphorylation been chemically
verified?
RAO: Not in this enzyme.
FALKE: In other related enzymes?
RAO: Yes, in several pumps that are related. I think there is no doubt
that this aspartate is phosphorylated because of its strict conservation
with other enzymes.
ROGER KOEPPE II: Is phosphorylation of aspartate 378 a prerequi-
site for processing? For homologous proteins, is phosphorylation of a
residue equivalent to aspartate 378 required for processing?
RAO: That is a possibility. We don't know if the mutants form a
phosphoenzyme intermediate. There is no information available in
homologous systems on the requirements of the phosphorylated
residue in processing.
KOEPPE: Does glutamate 378 become phosphorylated in the mutant?
RAO: There is information from homologous ATPases that any
replacement of the equivalent aspartate does not work. Only the
wild-type is phosphorylated.
KOEPPE: Is kinase-mediated phosphorylation a prereqUisite for
processing? If so, has the extent of phosphorylation of the unprocessed
mutants (position 378 and K379Q) been measured? This may offer an
assessment of whether the unprocessed mutant proteins are correctly
folded.
RAO: We know that the extent of kinase-mediated phosphorylation of
this protein increases as it progresses along the secretory pathway and
is maximal at the cell surface. We do not know if this phosphorylation
is a prerequisite for processing. Activation of the ATPase by glucose at
the cell surface has been shown to be paralleled by a phosphorylation
event. The experiment is being done.
VICTOR LEMAS: Is there evidence for insoluble small proteins of
interest associated with the secretory vesicles?
RAO: There is no evidence for other proteins required for activity.
LEMAS: How about at some transient stage?
RAO: It is possible that there is some protein component of the
secretory machinery required for processing of the ATPase. Amounts
of ATPase that can be processed are saturable. Also, coexpression
with aspartate 378 mutants impairs processing of the wild-type
ATPase.
LEMAS: Have you expressed your mutant behind a GALl promoter
to see if the ATPase gets to the cell surface?
RAO: Yes, but the 378 mutants appear not to get to the cell surface.
LEMAS: So, the temperature shift does not cause problems?
RAO: No, the processing problem appears not to be related to
temperature upshift.
KUNIO TAKEYASU: I'm curious if you can express the calcium or
sodium/potassium pump? Does it go to secretory vesicles?
RAO: I don't know, Bob Farley might know this for the Na+ /K+
ATPase.
ROBERT FARLEY: We haven't looked specifically in different
membranes, but it would probably go through the secretory vesicles to
the plasma membrane where we know it eventually is found.
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RAO: The Na+ /K+ pump appears to be a good candidate for
expression in secretory residues. In yeast the secretory pathway can be
interrupted by t.s. secretory mutants allowing the accumulation of
distinct compartments: e.g., ER, Golgi, and secretory vesicles. The
Na+ /K+ ATPase may be targeted to anyone of these compartments.
FARLEY: What fraction of proteins in secretory vesicles is driven by
the mutant promoter, 1, 1O,90%?
RAO: As determined by densitometric scans of gels, 5-8% of total
protein in both secretory vesicles and plasma membranes.
FARLEY: Another comment about vanadate, which is a phosphate
analogue of the transition state. Changes in the K j for vanadate may be
telling you about residues that participate in the hydrolysis of nucleo-
side triphosphates.
DOUGLAS FAMBROUGH: Is there a vanadate resistant mutant in a
different region around 230 or 240?
RAO: Yes, in Schizosaccharomyces pombei at residue 270. Addition-
ally, ten amino acids upstream from aspartate 378, a serine to
phenylalanine mutation results in vanadate resistance.
EDWARD RABON: What are the yields of enzyme?
RAO: As mentioned, 5-8% in purified secretory vesicles. Yeast can be
grown both inexpensively and abundantly. One can obtain 1 mg of
purified secretory vesicles per liter of exponentially-growing cells. This
preparation can be scaled up in fermenters to provide mg amounts of
ATPase for biophysical studies e.g., fluorescent labeling.
RABON: How is specific expression standardized?
RAO: Specific expression is standardized by an immunodot blot
procedure. Known amounts of secretory vesicles containing wild-type
or mutant ATPase are spotted on a filter and treated with polyclonal
anti-ATPase antibody followed by 125I-protein A. Samples are excised
and radioactivity determined. Relative amounts of mutant ATPase are
determined from a standard curve of wild type ATPase.
GORDON RULE: The selection of mutant sites by homology is
dangerous, especially where there are no crystallographic studies. Are
there any other experiments on distantly related enzymes that would
indicate that mutants are not structural effects?
RAO: We think that evolutionarily-conserved residues provide a good
starting point for mutagenesis. We are also using other approaches,
e.g., we are mutating charged residues in the membrane and residues
identified by chemical modification studies. In addition, we have begun
to generate random mutations in selected regions of interest in
conjunction with a phenotypic selection scheme.
DAVID BUSATH: Are there any soluble proteins whose structures
are known that are homologous that bind and hydrolyze ATP?
RAO: There are many soluble ATP-binding proteins of known
structure e.g., dehydrogenase and kinases. They have characteristic
sequence motifs (Walker A and B) and secondary structures (alternat-
ing helices and strands) that allow us to model the ATP-binding fold of
P-type ATPases.
RULE: Typically, the sequence homology for ATP binding sites in the
Rossman fold are extremely low. It is difficult to predict in the absence
of crystallographically determined structures.
RAO: Different algorithms have predicted alternating a-helices and
[3-strands, diagnostic of ATP-binding folds. Also, residues labeled by
ATP-affinity analogues map to this region.
RULE: That is much stronger than secondary structure predictions
alone.
JUAN BALLESTEROS: Did you examine the acidic region of 12
negatively charged residues on the amino terminus? Is there a function
similar to other proteins containing "runs" of acidic residues?
RAO: We have no information on this acidic region.
RABON: In general, mutation studies provide valuable information of
functionally important residues, but to what extent does this informa-
tion actually define the phosphate binding pocket? Do you plan
investigations of rescue mutations of the phosphate binding domains?
RAO: There is much to do before we "define" the phosphate binding
pocket. We are starting to make more mutants. As far as rescue
mutations, there is another interesting phenotype that mutants exhibit,
they are dominant lethals. If expressed constitutively, the yeast die. In
time one sees revertant colonies. We sequence these to determine the
change; some of these are full reversions. We are searching for
second-site revertants.
MARC GLUCKSMAN: Ifyou compare wild-type data in Tables 1 and
2 there seems to be significant differences in specific activity and
sensitivity to vanadate. Is this due to variations in batch-to-batch
preparations solely due to expression?
RAO: We do not see much batch-to-batch variation in apparent K j for
vanadate and pH optimum of the enzyme.
GLUCKSMAN: Do you have upstream and downstream sequences
from the gene in your plasmid construct?
RAO: The upstream sequences are derived from the yeast cytochrome
c gene, including the TATA box and transcription start sites. The
PMAI promoter has been replaced by a yeast heat shock element.
GLUCKSMAN: Have you found any orientations in the secretory
vesicles where you may get mixed orientations in the membrane
allowing the ATPase to point in and out?
RAO: From what we know of vesicle formation and fusion we expect
the vesicles to be homogeneously oriented with the large hydrophilic
domains of the ATPase facing outward. We see no experimental
evidence for mixed populations of vesicles, for example, there is no
"unmasking" of ATPase activity upon vesicle lysis.
GLUCKSMAN: It is intriguing that in the aspartate 378 mutation
there is no activity with the glutamate 378 that changes the catalytic
site by 1.4 AN. Do you know of other P-type cation ATPases like Na/K
or Ca where mutagenesis was performed to substantiate this finding?
In aspartyl proteases or metalloenzymes by site-directed mutagenesis
of aspartate to glutamate or visa versa some detectable enzyme
activity.
RAO: The aspartate requirement appears to be stringent in the P-type
ATPases.
ALBERS: I'd like to know about the cell biology and biophysics of
these secretory vesicles. Are there pumps present in the vesicles that
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accumulate potassium? Is the expression of the proton pump associ-
ated with that system?
RAO: First, the role of the secretory vesicles is to convey proteins
destined for secretion to the cell surface by fusing with the plasma
membrane. Yeast accumulate potassium by high- and low-affinity
transporters, which are encoded by the TRKI and TRK2 genes,
respectively. We expect that these transporters are carried to the
plasma membrane via the secretory vesicles, however, we do not know
if they are functional in the vesicles.
ALBERS: You were talking of the possibility that the proton pump
functions in the secretory vesicles. In some other vesicle systems,
where the proton pump drives a secondary transport system, the
secondary transport system is actually driven by the membrane
potential and not by the proton gradient per se. I'm curious whether, in
these vesicles, a K+/H+ exchange is functioning. Work from Haber's
lab indicates that some proton pump mutants are rescued by high K+
in the media. I believe that their interpretation is that the membrane
potential is discharged. Their mutants were incorporated into the
plasma membrane rather than in secretory vesicles.
RAO: We do not know whether a K+ /H+ exchanger (or any other K+
transport system) is functioning in the secretory vesicles. K+/H +
exchange is certainly a plausible explanation for the suppression of the
acid pH- and NH4+ ion-sensitivity of Haber's plasma membrane
ATPase mutants by adding high K+ to the medium. Acid pH and NH4 +
ions would be expected to dissipate transmembrane pH and potential
gradients, respectively, resulting in growth inhibition, while high
concentrations of external K+ could stimulate H+ efflux and thereby
rescue H+-ATPase mutants.
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